Opioid Risk Tool (ORT)
Opioid Risk Tool · Also known as: ORT
The ORT is a brief, 10-item self-report screening instrument designed to identify patients at elevated risk for opioid misuse, addiction, or aberrant drug-related behaviors prior to initiating opioid therapy. Developed by Webster and Webster in 2005, it stratifies patients into low, moderate, and high risk categories based on personal and family history of substance abuse, psychiatric comorbidity, and psychosocial factors. The ORT is widely used in pain management and primary care settings to guide shared decision-making and risk mitigation strategies when prescribing opioids.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The ORT is appropriate for use in pain management clinics, primary care practices, emergency departments, and other settings where opioid prescribing decisions are made. It is specifically designed for patients with chronic pain being considered for long-term opioid therapy. The ORT should be administered prior to opioid initiation to inform prescribing decisions and risk mitigation planning. It is less useful in acute pain settings where brief opioid exposure is planned, or in patients with established opioid dependence being transitioned to opioid maintenance therapy.
Strengths & limitations
- Brief, validated screening instrument requiring minimal time and no special equipment or training
- Identifies gender-specific risk factors that may affect opioid misuse vulnerability
- Stratifies risk into clinically meaningful categories that inform monitoring intensity and therapeutic approach
- Demonstrated sensitivity and specificity for predicting aberrant drug-related behaviors in opioid-treated patients
- Widely used in pain management and primary care with substantial clinical utility and acceptance
- Relies on self-report and may be subject to underreporting of sensitive information (substance abuse, legal history) due to social desirability
- Does not assess all relevant risk factors (e.g., concurrent benzodiazepine use, active psychiatric instability) that may influence misuse risk
- Risk categories are based on retrospective validation data and may not generalize equally across diverse demographic or clinical populations
- Does not provide ongoing risk monitoring; risk may change during opioid therapy as new information emerges
Frequently asked
Does a high ORT score mean I will become addicted to opioids?
No. A high ORT score indicates elevated risk based on documented personal and family history, but does not predict addiction with certainty. Many high-risk individuals use opioids appropriately when provided with intensive monitoring, psychosocial support, and structured agreements. Risk mitigation strategies can substantially reduce misuse likelihood.
Can the ORT be used to monitor opioid risk during treatment?
The ORT is designed primarily for pre-treatment risk assessment. During opioid therapy, ongoing clinical assessment (including periodic reassessment of psychosocial factors), urine drug screening, and behavioral monitoring are more appropriate. The ORT can be readministered annually or when significant life changes occur.
What should I do if my ORT score is high?
A high ORT score does not exclude you from opioid therapy, but indicates that intensive monitoring and risk mitigation strategies are needed. Discuss with your physician strategies such as more frequent office visits, urine drug screening, psychiatric or addiction medicine consultation, behavioral contracts, and consideration of alternative pain management approaches.
How accurate is the ORT at predicting opioid misuse?
The ORT has moderate sensitivity and specificity for identifying individuals who engage in aberrant behaviors when prescribed opioids. It is effective at risk stratification but cannot perfectly predict individual behavior. Combined with clinical judgment and ongoing monitoring, it improves outcomes.
Are the ORT scores different for men and women?
Yes. The ORT uses gender-specific items and scoring because males and females have different risk factor profiles. Males are asked about alcohol and drug use; females are asked about depression and anxiety. This improves accuracy of risk assessment in each gender.
Can the ORT be used for patients taking opioids for cancer pain or end-of-life care?
The ORT was developed and validated for chronic non-cancer pain populations. Its applicability to cancer pain or palliative care has not been thoroughly studied; clinical judgment about risk versus benefit is essential in these contexts, as opioid undertreatment risks are also important.
Sources
- Webster, L. R., & Webster, R. M. (2005). Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432–442. DOI: 10.1111/j.1526-4637.2005.00072.x ↗
How to cite this page
ScholarGate. (2026, June 3). Opioid Risk Tool. ScholarGate. https://scholargate.app/en/addiction-medicine/opioid-risk-tool
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- BAMAddiction Medicine↔ compare
- DUDITAddiction Medicine↔ compare
- SADQAddiction Medicine↔ compare
- SASSIAddiction Medicine↔ compare